ABBOTICIN

Brand name authorized in: Estonia Finland

Active ingredients

The drug ABBOTICIN contains one active pharmaceutical ingredient (API):

1 Erythromycin
UNII 63937KV33D - ERYTHROMYCIN

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.

Read about Erythromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Erythromycin
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
EE
Ravimiamet
Identifier(s): 1748976
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 004721, 405001